Learn more about fair tests of treatments

The purpose of this section of the site is to highlight important learning resources that will help you to improve your own and others’ understanding of fair tests of treatments.

They are all listed chronologically below, most recent additions first. However, you can also browse by Resource type (including target audience) and Topic using the menus on the right.

If you know of any such resources that you think we should add, please do let us know so we can take a look.

AllTrials logo

AllTrials (All Trials Registered | All Results Reported) aims to correct the appalling state of affairs we find ourselves in, in which studies remain unpublished or are published but with selective reporting of the outcomes.

Testing Treatments interactive wholeheartedly supports this initiative.  Only if we have full disclosure of all trial data can we properly evaluate the effectiveness of treatments. Continue reading »

Detail from the Bayeux Tapestry

Sadly, no matter how many times you say it, you will still see headlines like:

All of the above claims are unfounded, based on the evidence the stories themselves were based on.

So, in an effort to help you explain this phenomenon, and understand why it’s important not to be misled by it, we have put together a small collection of resources. Continue reading »

Premature baby

In this YouTube video, John Lantos explains a dangerously flawed ethical analysis which results in it being much harder to obtain consent for a clinical trial to test an untested treatment than it is to prescribe that same treatment for patients in everyday clinical practice. Continue reading »

Breaking the bank to panic-buy harmful drugs

In November 2012 we wrote about Roche’s refusal to release clinical research data relevant to independent assessment of the effects of Tamiflu, and to the campaign to gain access to all of the data.

That campaign has now succeeded, and the full clinical data set has been analysed by Cochrane reviewers. The conclusions are of great importance.

Continue reading »

ECRAN logo

This lay-friendly video was created by the European Communication on Research Awareness Needs (ECRAN) Project.  The engaging 5-minute animation is available in 23 languages and is aimed at a lay audience, or those with little knowledge about clinical trials. The ECRAN group have also produced a great powerpoint presentation explaining clinical trial for patients. Continue reading »

A crowd holding a megaphone

This section of Testing Treatments interactive has been created to help patients and members of the public who wish to promote better research for better health care.

We’ll be developing this section throughout 2014 in partnership with some of the groups listed below. In the meantime, we’ve provided some resources to get you started.

Continue reading »

No bullshit

Most people know that medical treatments sometimes do more harm than good; but too few people know about how fair tests can help us recognize harmful or useless treatments. This information isn’t part of everyone’s general knowledge.  And that’s why learning about fair tests of treatments is so important. Continue reading »

Students for best evidence logo

Students 4 Best Evidence (S4BE) is a growing network of students from around the world, from school age to university, who are interested in learning more about evidence-based healthcare (EBH).  The network is supported by the UK Cochrane Centre.  In addition to the website, the S4BE has a Facebook group and Twitter feed.

Norah Essali’s video introduction tells you all about S4BE and how you can get involved.

Continue reading »

Generation R logo

In September 2013, the NIHR Medicines for Children Research Network’s ran a groundbreaking event: Generation R. Generation R was conceived, written and run by their Young Person’s Advisory Group. The event sought to engage the life-sciences industry in the importance of children’s research and the invaluable role young people have to play in its development.

Continue reading »

A crowd holding a megaphone

“Now then”, you are probably saying, “there’s no such thing…!”  And rightly so, familiar as you are with how perverse incentives can distort tests of treatments.

That said, in these times of austerity, one should never underestimate the importance of a proper feed in encouraging user engagement. Continue reading »